Angiotech receives favourable decision from the European Patent Office EPO
The EPO's Technical Board of Appeal rejected the attempt by Conor Medsystems Inc. and Sahajanand Medical Technologies Pvt. Ltd. to intervene and appeal an earlier decision by the Opposition Division of the European Patent Office, which upheld the Hunter patent. The decision found that these appeals were "inadmissible."
"We are pleased with the EPO's decision, and Angiotech views this outcome as yet another confirmation of the strength and validity of our patent portfolio," said Dr. William Hunter, President and CEO of Angiotech.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.